Ocular Therapeutix, Inc. (OCUL)
NASDAQ·Healthcare·Biotechnology
$9.63
+7.77%
Mkt Cap $1.91B
Analyst Ratings
Buy
6
Hold
0
Sell
0
Price Target (12 analysts)
$25.50
Range $21.00 – $30.00
Implied Upside
+164.9%
Consensus $25.50 vs current $9.63
NASDAQ·Healthcare·Biotechnology
$9.63
+7.77%
Mkt Cap $1.91B
Buy
6
Hold
0
Sell
0
Price Target (12 analysts)
$25.50
Range $21.00 – $30.00
+164.9%
Consensus $25.50 vs current $9.63